Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
59,964,750
-
Total 13F shares
-
40,641,834
-
Share change
-
-492,641
-
Total reported value
-
$648,298,745
-
Put/Call ratio
-
90%
-
Price per share
-
$15.95
-
Number of holders
-
140
-
Value change
-
-$10,122,917
-
Number of buys
-
79
-
Number of sells
-
62
Institutional Holders of Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) as of Q4 2016
As of 31 Dec 2016 Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) had 140 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 40,641,834 shares of stock of the company.
Largest 10 holders included Palo Alto Investors, LLC, DEERFIELD MANAGEMENT CO, BlackRock Fund Advisors, GREAT POINT PARTNERS LLC, VANGUARD GROUP INC, MORGAN STANLEY, STATE STREET CORP, MACQUARIE GROUP LTD, ACADIAN ASSET MANAGEMENT LLC, and BlackRock Institutional Trust Company, N.A..
This table shows 140 institutional shareholders of the security as of 31 Dec 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.